Prime-A-Pump is a web-based knowledge resource and collaboration tool for building and maintaining smart-pump drug libraries. Zynx Health claims, Prime-A-Pump helps in improving the safety, quality and efficiency
The placebo controlled, randomized and single blind trial is intended to investigate the safety and efficacy o f ADXS-HPV in around three different dose cohorts. The company expects
Developed by using MonoSol Rx’s PharmFilm technology, Zuplenz is a film formulation that delivers either 4 or 8mgs of ondansetron. Zuplenz helps in preventing postoperative, highly and moderately
The agreement allows Amgen to develop and commercialize BiTE antibodies against two of the undisclosed targets which will be selected by Amgen. Amgen will be responsible to develop,
The double-blind, randomized and placebo-controlled trial showed dose-proportional pharmacokinetic exposure over the tested dose range. In the trial, the terminal half-life was approximately 20 hours. The trial investigated
The trial aims to evaluate the safety and efficacy of CRLX101 in patients with advanced NSCLC whose disease has progressed following one or two prior regimens of therapy.
Jones joined Acura in April 2008 as the senior vice president and COO and was reponsible for products development, which use the company’s proprietary abuse deterrent technologies. Acura’s
The deal allows Phillips to broaden its medical business manufacturing capabilities. Medisize provides services to drug delivery devices, primary pharmaceutical packaging, medical and diagnostic devices and airway management.
As per the terms of the agreement, Probiomed is responsible for seeking regulatory approval for Fanapt in Mexico. However, Vanda will be responsible for supplying the drug to
As per the terms of the agreement, Antares Pharma is entitled to receive milestone payments on achieving regulatory approval and certain sales level from Watson. Antares Pharma is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.